Agnès BUZYN

Agnès Buzyn is Professor of Hematology at the Paris-Sorbonne University in Paris. She spent a large part of her career as an academic hematologist and clinician at the University Paris Descartes - Necker Hospital, where from 1992 to 2011 she headed the adult hematology intensive care and bone marrow transplants unit. In addition, up to 2006, she led research team on tumor immunology at the National Institute of Health and Medical Research (INSERM) - Institut Cochin. Her research activities have focused on bone marrow transplants, and immunotherapeutic vaccine for Leukemias (CML and AML). She has published more than 150 scientific papers and reviews in this area. Throughout her career, A. Buzyn has served as president or board member of a number of national organizations: The Biomedicine Agency (ABM), the Blood Institute (EFS), the Bone Marrow Transplant and Cell Therapy Society (SFGM-TC). From 2008 to 2013, she served as Chair of the Executive Board of the Radioprotection and Nuclear Safety Institute (IRSN). During her mandate, she had to manage the short-term and long-term consequences of the Fukushima accident with the French government. A. Buzyn was the executive President of the French National Cancer Institute (INCa) from May 2011 until February 2016, in charge of designing the French Cancer Control Plan. In 2016, she was appointed Chairman of the French National Authority for Health (HAS - Haute Autorité de santé), the French Health Technology Assessment agency in charge of evaluating the benefit of drugs and medical devices, accreditation of hospitals and drafting guidance for French health professionals. She served as the French Ministry of Solidarity and Health from May 2017 to February 2020, during the first mandate of President Macron, drafting the pension reform, and making amid many reforms on the health and solidarity field, 11 vaccines mandatory for the French children. She joined January 2021 as an Assistant Director General, serving as the DG's envoy for multilateral affairs,also serving as the Executive Director of the WHO Academy. In September 2022, she was named Advisor in the French Court of Auditors. In parallel, she launched in March 2025 a new think tank, Evidences, dedicated to the place of Acince in the society.